Harrow Health, Inc. (HROW) ownership: insiders 21% · institutions 54% · index and ETF funds 5% (13F 2026-03-31). Insider activity, 90 days: 1 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Opaleye Management Inc. | 2832230.00 | $99.86M | 7.6% | 2026-03-31 |
| BlackRock | 2552759.00 | $90.01M | 6.8% | 2026-03-31 |
| Vanguard | 1963913.00 | $69.25M | 5.3% | 2026-03-31 |
| Private Capital Management, LLC | 1562000.00 | $55.08M | 4.2% | 2026-03-31 |
| Luxor Capital Group, LP | 1119400.00 | $39.47M | 3.0% | 2026-03-31 |
| State Street | 855047.00 | $30.15M | 2.3% | 2026-03-31 |
| Geode Capital Management | 852034.00 | $30.05M | 2.3% | 2026-03-31 |
| Marshall Wace | 644918.00 | $22.74M | 1.7% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-05-18 | |
| Buy | null | 2026-05-18 |
Back to HROW overview · HROW earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.